A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects

Authors

Institutions

Publication Details

Journal
Clinical Therapeutics
Published
2024-08-01
DOI
https://doi.org/10.1016/j.clinthera.2024.06.018
Citations
2
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.91
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects

Chaoying Hu, Wanling Sun, Xiangrong Zhang, Yuanyuan Wu et al.
2 citations
Clinical Therapeutics
Erythropoietin and Anemia Treatment
0.91
article

A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects

Chaoying Hu, Wanling Sun, Xiangrong Zhang, Yuanyuan Wu, Junlong Huang, Lan Zhang
article en
2 citations

Abstract

No abstract available for this paper.
Clinical TherapeuticsVol. 46(8)
Capital Medical University (CN)
Openalex Percentile: Top 24%
Erythropoietin and Anemia Treatment
0.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.